Cargando…

External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study

We externally validated the fatty liver index (FLI), the lipid accumulation product (LAP), the hepatic steatosis index (HSI), and the Zhejiang University index (ZJU) for the diagnosis of fatty liver (FL) and non-alcoholic fatty liver disease (NAFLD) in the general population. The validation was perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foschi, Francesco Giuseppe, Conti, Fabio, Domenicali, Marco, Giacomoni, Pierluigi, Borghi, Alberto, Bevilacqua, Vittoria, Napoli, Lucia, Berardinelli, Dante, Altini, Mattia, Cucchetti, Alessandro, Ercolani, Giorgio, Casadei-Gardini, Andrea, Bellentani, Stefano, Gastaldelli, Amalia, Tiribelli, Claudio, Bedogni, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867182/ https://www.ncbi.nlm.nih.gov/pubmed/33535679 http://dx.doi.org/10.3390/jcm10030520

Ejemplares similares

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2018)

Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study
por: Rimini, Margherita, et al.
Publicado: (2020)

A simple index of lipid overaccumulation is a good marker of liver steatosis
por: Bedogni, Giorgio, et al.
Publicado: (2010)

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials
por: Casadei Gardini, Andrea, et al.
Publicado: (2019)

The Perceived Ability of Gastroenterologists, Hepatologists and Surgeons Can Bias Medical Decision Making
por: Cucchetti, Alessandro, et al.
Publicado: (2020)

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
por: Bedogni, Giorgio, et al.
Publicado: (2006)

Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
por: Marisi, Giorgia, et al.
Publicado: (2018)

Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature
por: Loggi, Elisabetta, et al.
Publicado: (2016)

Association of serum lipids with β-cell function in obese children and adolescents
por: Bedogni, Giorgio, et al.
Publicado: (2019)

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
por: Carli, Fabrizia, et al.
Publicado: (2023)

Silencing efficacy prediction: a retrospective study on target mRNA features
por: Pascut, Devis, et al.
Publicado: (2015)

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
por: Solaini, Leonardo, et al.
Publicado: (2019)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
por: Gardini, Andrea Casadei, et al.
Publicado: (2018)

First 100 minimally invasive liver resections in a new tertiary referral centre for liver surgery
por: La Barba, Giuliano, et al.
Publicado: (2022)

ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
por: Marisi, Giorgia, et al.
Publicado: (2019)

Development and Internal Validation of Fatty Liver Prediction Models in Obese Children and Adolescents
por: Bedogni, Giorgio, et al.
Publicado: (2021)

Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia
por: Del Toro, Rossella, et al.
Publicado: (2023)

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
por: Gardini, Andrea Casadei, et al.
Publicado: (2016)

Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin
por: De Matteis, Serena, et al.
Publicado: (2019)

Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children
por: Bellarosa, Cristina, et al.
Publicado: (2021)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
por: Casadei Gardini, Andrea, et al.
Publicado: (2017)

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review
por: Gardini, Andrea Casadei, et al.
Publicado: (2017)

Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells?
por: Ercolani, Giorgio, et al.
Publicado: (2022)

Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2009)

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
por: Passardi, Alessandro, et al.
Publicado: (2019)

Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663
por: Passardi, Alessandro, et al.
Publicado: (2020)

Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy
por: Binda, Cecilia, et al.
Publicado: (2022)

Direct Endoscopic Necrosectomy of a Recurrent Walled-Off Pancreatic Necrosis at High Risk for Severe Bleeding: A Hybrid Technique Using a Dedicated Device
por: Binda, Cecilia, et al.
Publicado: (2023)

Combined Kidney-Liver, Heart-Liver, and Kidney-Pancreas Transplantations from a Single Deceased Donor
por: Ravaioli, Matteo, et al.
Publicado: (2012)

Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study
por: Palmese, Francesco, et al.
Publicado: (2022)

Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy
por: Qiao, Guoliang, et al.
Publicado: (2016)

Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017)

Variations in risk‐adjusted outcomes following 4318 laparoscopic liver resections
por: Cucchetti, Alessandro, et al.
Publicado: (2022)

Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals
por: Pascut, Devis, et al.
Publicado: (2019)

Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases
por: Binda, Cecilia, et al.
Publicado: (2022)

Measuring and estimating insulin resistance in clinical and research settings
por: Gastaldelli, Amalia
Publicado: (2022)

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer
por: Rapposelli, Ilario Giovanni, et al.
Publicado: (2021)

Albumin-bilirubin score: an additional tool for the management of patients with hepatocellular carcinoma
por: Serenari, Matteo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1amjpg7ti31srf6s6vp81urob3